Mingzhi Han

1.9k total citations
39 papers, 1.2k citations indexed

About

Mingzhi Han is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mingzhi Han has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Mingzhi Han's work include Glioma Diagnosis and Treatment (12 papers), RNA Research and Splicing (7 papers) and MicroRNA in disease regulation (5 papers). Mingzhi Han is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), RNA Research and Splicing (7 papers) and MicroRNA in disease regulation (5 papers). Mingzhi Han collaborates with scholars based in China, Norway and Luxembourg. Mingzhi Han's co-authors include Xingang Li, Anjing Chen, Jian Wang, Bin Huang, Rolf Bjerkvig, Ning Yang, Frits Thorsen, Yangyang Xu, Qing Zhang and Yang Kong and has published in prestigious journals such as PLoS ONE, Brain and Oncogene.

In The Last Decade

Mingzhi Han

38 papers receiving 1.2k citations

Peers

Mingzhi Han

PRM

ONCOL

IMMUN

Linda J. Metheny‐Barlow United States

Gabriel Leprivier Germany

Yanyang Tu China

Ye Song China

Shujun Lin China

Michal Grzmil Switzerland

Sharmistha Chakraborty United States

Michael Ronellenfitsch Germany

Carmela Ciccarelli Italy

Linda J. Metheny‐Barlow United States

Mingzhi Han

755 ×0.9

434 ×1.0

410 ×1.6

PRM

377 ×1.8

ONCOL

151 ×1.0

IMMUN

Citations per year, relative to Mingzhi Han Mingzhi Han (= 1×) peers Linda J. Metheny‐Barlow

Countries citing papers authored by Mingzhi Han

Since Specialization

Citations

This map shows the geographic impact of Mingzhi Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhi Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhi Han more than expected).

Fields of papers citing papers by Mingzhi Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzhi Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhi Han. The network helps show where Mingzhi Han may publish in the future.

Co-authorship network of co-authors of Mingzhi Han

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzhi Han. A scholar is included among the top collaborators of Mingzhi Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzhi Han. Mingzhi Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Zhiwei, Xuehai Zhang, Bo Mao, et al.. (2025). Dual role of WNT10A in promoting the malignancy of glioblastoma and remodeling the tumor microenvironment. Neuro-Oncology. 27(9). 2232–2249. 1 indexed citations

Wu, Yibo, Chen Yang, Xuehai Zhang, et al.. (2025). Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma. Scientific Reports. 15(1). 954–954. 2 indexed citations

Zhao, Wenbo, Yibo Wu, Shuai Wang, et al.. (2024). HTRA1 promotes EMT through the HDAC6 /Ac‐α‐tubulin pathway in human GBM cells. CNS Neuroscience & Therapeutics. 30(2). e14605–e14605. 4 indexed citations

Zhao, Wenbo, Yibo Wu, Wenyu Liu, et al.. (2022). Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas. Journal of Translational Medicine. 20(1). 494–494. 2 indexed citations

Xu, Yang, Yan Zhang, Zhiwei Xue, et al.. (2022). TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein. Journal of Experimental & Clinical Cancer Research. 41(1). 336–336. 20 indexed citations

Han, Mingzhi, et al.. (2022). Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas. Frontiers in Immunology. 13. 1025286–1025286. 9 indexed citations

Zhang, Xin, Xuehai Wang, Ran Xu, et al.. (2021). Correction to: YM155 decreases radiation-induced invasion and reverses epithelial–mesenchymal transition by targeting STAT3 in glioblastoma. Journal of Translational Medicine. 19(1). 407–407. 2 indexed citations

Han, Mingzhi, et al.. (2020). Endogenously expressed CXC chemokine receptor type 7 is involved in inflammation of chondrocyte from mice. Osteoarthritis and Cartilage. 28. S124–S124. 1 indexed citations

Sun, Tao, et al.. (2020). Potential sphingosine-1-phosphate-related therapeutic targets in the treatment of cerebral ischemia reperfusion injury. Life Sciences. 249. 117542–117542. 15 indexed citations

10.

Kong, Yang, Zichao Feng, Anjing Chen, et al.. (2019). The Natural Flavonoid Galangin Elicits Apoptosis, Pyroptosis, and Autophagy in Glioblastoma. Frontiers in Oncology. 9. 942–942. 104 indexed citations

11.

Han, Mingzhi, Shuai Wang, Wenbo Zhao, et al.. (2019). Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma. EBioMedicine. 43. 159–170. 37 indexed citations

12.

Han, Mingzhi, Ran Xu, Shuai Wang, et al.. (2018). Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion. Neoplasia. 20(6). 543–554. 76 indexed citations

13.

Zhang, Xin, Qibing Huang, Xuehai Wang, et al.. (2017). Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair. Biomedicine & Pharmacotherapy. 94. 627–635. 21 indexed citations

14.

Xu, Ran, Jianxiong Ji, Xin Zhang, et al.. (2017). PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT. Journal of Experimental & Clinical Cancer Research. 36(1). 193–193. 38 indexed citations

15.

Han, Mingzhi, Ran Xu, Yangyang Xu, et al.. (2017). TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas. Journal of Experimental & Clinical Cancer Research. 36(1). 155–155. 53 indexed citations

16.

Xu, Ran, Mingzhi Han, Yangyang Xu, et al.. (2017). Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas. Journal of Translational Medicine. 15(1). 165–165. 22 indexed citations

17.

Han, Mingzhi, Youn‐Kwan Jung, S.E. Usmani, et al.. (2015). CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation. Osteoarthritis and Cartilage. 23(6). 966–974. 25 indexed citations

18.

Han, Mingzhi, Wei‐Liang Chen, Ying He, et al.. (2015). KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP. Oncology Reports. 35(2). 971–977. 26 indexed citations

19.

Han, Mingzhi, Ya Zhang, Bin Huang, et al.. (2015). Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis. Molecular Neurobiology. 53(1). 720–727. 33 indexed citations

20.

Han, Mingzhi, et al.. (2014). Calcineurin/nfat signaling in chondrocyte differentiation: NFAT is a crucial negative regulator of early chondrogenesis. Osteoarthritis and Cartilage. 22. S171–S171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact